Work

[Research advances in withdrawal of nucleos(t)ide analogues in chronic hepatitis B patients].

Year: 2016

Type: review

Abstract: Withdrawal of nucleos(t)ide analogues in chronic hepatitis B patients has always been a clinical problem for scholars and patients. Many studies showed that the withdrawal of nucleos(t)ide analogues often leads to a high recurrence rate in clinical practice. The factors such as age, baseline HBV DNA load, time of drug consolidation therapy, and HBsAg level are associated with recurrence after withdrawal of nucleos(t)ide analogues. In addition, there are many studies on safety after withdrawal of nucleos(t)ide analogues and response to retreatment after recurrence. This article reviews the research advances in the aspects mentioned above.

Source: PubMed

DOI: 10.3760/cma.j.issn.1007-3418.2016.09.015

Authors: N Hu, H You

Institutions: Shandong Medical College, Capital Medical University, Beijing Friendship Hospital

Language: English

Topic: Hepatitis B Virus Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W2542010746

FWCI:

Cites:

Cited by:

Related to: 10